methylphenidate hydrochloride extendedrelease methylphenidate hydrochloride tablet

1 INDICATIONS AND USAGE Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies ( 14 )] . Methylphenidate hydrochloride extended-release tablets USP are a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65. ( 1 )

specgx llc

FDA Reported Adverse Reactions
`[1] pyrexia` `[2] death` `[3] drug ineffective` `[4] fatigue` `[5] nausea` `[6] rash` `[7] diarrhoea` `[8] vomiting` `[9] headache` `[10] malignant neoplasm progression`

4 years ago

OVAL GREY M 27

4 years ago

M 27 OVAL GREY

16 HOW SUPPLIED/STORAGE AND HANDLING Strength Color Tablet Description Bottle Count NDC 27 mg gray capsule shaped, imprinted with “M” in a box and “27” on one side in black ink 100 0406-0127-01 36 mg white capsule shaped, imprinted with “M” in a box and “36” on one side in black ink 100 0406-0136-01 54 mg red capsule shaped, imprinted with “M” in a box and “54” on one side in black ink 100 0406-0154-01 Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from humidity. Dispense in tight, light-resistant container with child-resistant closure.

More pills like OVAL M 27

Related Pills

BX Rating 24 HR Methylphenidate Hydrochloride 54 MG Extended Release Oral Tablet

SpecGx LLC

methylphenidate hydrochloride 36 MG 24 HR Extended Release Tablet

Mallinckrodt, Inc.

tamoxifen 20 MG Oral Tablet

Mylan Pharmaceuticals Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site